Homepage
Open in app
Sign in
Get started
Backing tech disruptors.
News
Portfolio stories
Exits
Elaia
Previous articles
Learn more
Follow
Elaia
Startup Tech Call Assessments: A Tech-Intensive VC’s Perspective
Startup Tech Call Assessments: A Tech-Intensive VC’s Perspective
By Marc Rougier & Dimitri. Edited by Anya Brochier & Louisa Mesnard.
Elaia
Apr 10
Do I really need (and if so, when) a Chief of Staff?
Do I really need (and if so, when) a Chief of Staff?
The latest installment in our role-focused series — next up is the Chief of Staff, an elusive yet often indispensable role for startups…
Elaia
Mar 25
Synthetic Data (or: how to prevent the heat death of Machine Learning)
Synthetic Data (or: how to prevent the heat death of Machine Learning)
By Arturo Ancira García. Edited by Anya Brochier, Louisa Mesnard and Marc Rougier.
Elaia
Feb 22
Deep Tech Founders: Why You Need A CPO (If You Don’t Already Have One)
Deep Tech Founders: Why You Need A CPO (If You Don’t Already Have One)
Written by Marc Rougier. Edited by Anya Brochier and Louisa Mesnard.
Elaia
Jan 24
Lazard and Elaia Partners Enter into Exclusive Negotiations for a Strategic Partnership to Develop…
Lazard and Elaia Partners Enter into Exclusive Negotiations for a Strategic Partnership to Develop…
Lazard and Elaia Partners plan to launch a late-stage and growth equity fund focused on Europe and managed by a new jointly owned asset…
Elaia
Dec 14, 2023
Mablink Bioscience and Elaia: A Symbiotic Partnership
Mablink Bioscience and Elaia: A Symbiotic Partnership
Written by Florian Denis with assistance from Anya Brochier, David Sourdive, Louisa Mesnard, and Marc Rougier.
Elaia
Dec 5, 2023
The Impact of GenAI from the lens of Bain, Google and L’Oréal at Elaia
The Impact of GenAI from the lens of Bain, Google and L’Oréal at Elaia
Featuring voices from Bain, Google and L’Oréal
Elaia
Nov 29, 2023
What Impact Could Generative AI Have on Drug Discovery? Part II
What Impact Could Generative AI Have on Drug Discovery? Part II
By Florian Denis, with assistance from Marc Rougier, Louisa Mesnard and Anya Brochier
Elaia
Oct 26, 2023
What impact could Generative AI have on drug discovery? Part I
What impact could Generative AI have on drug discovery? Part I
By Florian Denis, with assistance from Louisa Mesnard and Anya Brochier
Elaia
Oct 24, 2023
Elaia’s 2022 Annual Sustainability Report is here!
Elaia’s 2022 Annual Sustainability Report is here!
Following an ESG (environmental, social, governance) framework, our third edition of Elaia’s Annual Sustainability Report evaluates how…
Elaia
Sep 25, 2023
GenAI, what new challenges will emerge from this revolution?
GenAI, what new challenges will emerge from this revolution?
Following the first chapter, “GenAI, a tsunami for the tech world” published on 1st August, here is the second chapter.
Xavier Lazarus
Sep 4, 2023
GenAI, a tsunami for the tech world
GenAI, a tsunami for the tech world
By Xavier Lazarus, with help from Justine Guers & Louisa Mesnard
Xavier Lazarus
Aug 1, 2023
Learnings from backing international deep tech
Learnings from backing international deep tech
Since the start of Elaia, we have always believed in the potential of backing entrepreneurs bringing forth a technological breakthrough.
Elaia
Jul 7, 2023
Startup Perspectives: From Product-Market-Fit to €10 million in sales
Startup Perspectives: From Product-Market-Fit to €10 million in sales
Sales is the name of the game for ambitious startups with a vision & a desire to change the status quo.
Elaia
Jun 21, 2023
The Finance Behind Startup Investing
The Finance Behind Startup Investing
by Xavier Lazarus
Elaia
Mar 27, 2023
Entrepreneur Stories: Why would a foreign entrepreneur set up their business in France?
Entrepreneur Stories: Why would a foreign entrepreneur set up their business in France?
By Armelle de Tinguy, Saish Rane with help from Marc Rougier
Elaia
Feb 9, 2023
Investing in Spain: opportunities and sunny outlooks
Investing in Spain: opportunities and sunny outlooks
(and we’re not even talking about the weather)
Elaia
Feb 3, 2023
Elaia’s 2022 year in review — A record year with changes in atmosphere
Elaia’s 2022 year in review — A record year with changes in atmosphere
By Xavier Lazarus with help from Marc Rougier, Saish Rane, Delphine Villuendas & Louisa Mesnard
Elaia
Jan 12, 2023
Health Data: Unlocking its full potential, at last
Health Data: Unlocking its full potential, at last
By Gabriel Franz, with the help of Samantha Jérusalmy, Sacha Loiseau, Marc Rougier, Saish Rane, Louisa Mesnard and Jean-David Zeitoun
Elaia
Nov 15, 2022
Cybersecurity is dead
Cybersecurity is dead
Crisis-time update from a European VC with 13 investments in Cyber
Elaia
Nov 3, 2022
Why is France becoming a major hub for digital health deep tech startups?
Why is France becoming a major hub for digital health deep tech startups?
By Benoît Georis with the help of Samantha Jérusalmy, Marc Rougier, Louisa Mesnard & Saish Rane
Elaia
Oct 20, 2022
A few thoughts on the current market evolutions — Chapter 5
A few thoughts on the current market evolutions — Chapter 5
By Xavier Lazarus, with help from Marc Rougier, Saish Rane, Justine Guers, Delphine Villuendas & Louisa Mesnard
Xavier Lazarus
Aug 25, 2022
A few thoughts on the current market evolutions — Chapter 4
A few thoughts on the current market evolutions — Chapter 4
By Xavier Lazarus, with help from Marc Rougier, Saish Rane, Justine Guers, Delphine Villuendas & Louisa Mesnard
Xavier Lazarus
Aug 18, 2022
A few thoughts on the current market evolutions — Chapter 3
A few thoughts on the current market evolutions — Chapter 3
By Xavier Lazarus, with the help from Marc Rougier, Saish Rane, Justine Guers, Delphine Villuendas & Louisa Mesnard
Xavier Lazarus
Aug 11, 2022
A few thoughts on the current market evolutions — Chapter 2
A few thoughts on the current market evolutions — Chapter 2
By Xavier Lazarus, with help from Marc Rougier, Saish Rane, Justine Guers, Delphine Villuendas & Louisa Mesnard
Xavier Lazarus
Aug 3, 2022
About Elaia
Latest Stories
Archive
About Medium
Terms
Privacy
Teams